PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Guenova, E.* ; Skabytska, Y.* ; Hoetzenecker, W.* ; Weindl, G.* ; Sauer, K.* ; Tham, M.* ; Kim, K.W.* ; Park, J.H.* ; Seo, J.H.* ; Ignatova, D.* ; Cozzio, A.* ; Levesque, M.P.* ; Volz, T.* ; Köberle, M.* ; Kaesler, S.* ; Thomas, P.* ; Mailhammer, R. ; Ghoreschi, K.* ; Schäkel, K.* ; Amarov, B.* ; Eichner, M.* ; Schaller, M.* ; Clark, R.A.* ; Röcken, M.* ; Biedermann, T.*

IL-4 abrogates TH17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells.

Proc. Natl. Acad. Sci. U.S.A. 112, 2163-2168 (2015)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Interleukin 4 (IL-4) can suppress delayed-type hypersensitivity reactions (DTHRs), including organ-specific autoimmune diseases in mice and humans. Despite the broadly documented antiinflammatory effect of IL-4, the underlying mode of action remains incompletely understood, as IL-4 also promotes IL-12 production by dendritic cells (DCs) and IFN-γ-producing TH1 cells in vivo. Studying the impact of IL-4 on the polarization of human and mouse DCs, we found that IL-4 exerts opposing effects on the production of either IL-12 or IL-23. While promoting IL-12-producing capacity of DCs, IL-4 completely abrogates IL-23. Bone marrow chimeras proved that IL-4-mediated suppression of DTHRs relies on the signal transducer and activator of transcription 6 (STAT6)-dependent abrogation of IL-23 in antigen-presenting cells. Moreover, IL-4 therapy attenuated DTHRs by STAT6- and activating transcription factor 3 (ATF3)-dependent suppression of the IL-23/TH17 responses despite simultaneous enhancement of IL-12/TH1 responses. As IL-4 therapy also improves psoriasis in humans and suppresses IL-23/TH17 responses without blocking IL-12/TH1, selective IL-4-mediated IL-23/TH17 silencing is promising as treatment against harmful inflammation, while sparing the IL-12-dependent TH1 responses.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
9.674
2.695
99
122
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Il-23 ; Il-4 ; Th17 ; Dendritic Cells ; Psoriasis; Dendritic Cells; Th2 Responses; Autoimmune Encephalomyelitis; Multiple-sclerosis; Interleukin (il)-4; Psoriasis-vulgaris; Murine Colitis; Cytokine; Therapy; Disease
Sprache englisch
Veröffentlichungsjahr 2015
HGF-Berichtsjahr 2015
ISSN (print) / ISBN 0027-8424
e-ISSN 1091-6490
Zeitschrift Proceedings of the National Academy of Sciences of the United States of America
Quellenangaben Band: 112, Heft: 7, Seiten: 2163-2168 Artikelnummer: , Supplement: ,
Verlag National Academy of Sciences
Verlagsort Washington
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Clinical Molecular Biology and Tumor Genetics (K.MOLBI)
POF Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-501400-001
PubMed ID 25646481
DOI 10.1073/pnas.1416922112
WOS ID WOS:000349446000078
Scopus ID 84923172388
Erfassungsdatum 2015-02-05
[➜Korrektur melden]